SPHERA FUNDS MANAGEMENT LTD. CLYM — ELIEM THERAPEUTICS INC

Ownership history in SPHERA FUNDS MANAGEMENT LTD.  ·  8 quarters on record

AI Ownership Summary

SPHERA FUNDS MANAGEMENT LTD. reported ELIEM THERAPEUTICS INC (CLYM) in 8 quarterly 13F filings from 2024 Q2 through 2026 Q1. Peak portfolio weight reached 0.72% in 2025 Q4. The latest visible filing shows CLYM at 0.46% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this CLYM ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was SPHERA FUNDS MANAGEMENT LTD.'s position in ELIEM THERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

CLYM was reported at 0.46% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.72% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q2 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CLYM stock page SPHERA FUNDS MANAGEMENT LTD. fund profile SPHERA FUNDS MANAGEMENT LTD. full holdings
How SPHERA FUNDS MANAGEMENT LTD. held CLYM — position size vs. price
% of Fund (quarterly)    CLYM price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 8 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED — — — 419,247 -513,000 -55.0% 0.46% $2.9M 2026-05-15 $10.80
2025 Q4 ADDED — — — 932,247 +497,410 +114.4% 0.72% $3.7M 2026-02-17 $5.61
2025 Q3 ADDED — — — 434,837 +225,000 +107.2% 0.18% $874K 2025-11-14 $1.90
2025 Q2 REDUCED 13.3% +60.5% ❌ 209,837 -32,098 -13.3% 0.06% $260K 2025-08-14 $1.72
2025 Q1 REDUCED — — — 241,935 -10,000 -4.0% 0.07% $295K 2025-05-15 $1.20
2024 Q4 ADDED — — — 251,935 +69,965 +38.4% 0.08% $453K 2025-02-14 $1.52
2024 Q3 REDUCED 15.4% -63.6% ✅ 181,970 -33,209 -15.4% 0.15% $926K 2024-11-14 $3.19
2024 Q2 INITIATED — — — 215,179 — — 0.21% $1.5M 2024-08-14 $6.01

🏢 Other funds also holding CLYM

As of 2026 Q1 — sorted by position size

GREAT POINT PARTNERS LLC 3Y 7Y 2.1% MPM BioImpact LLC 3Y 1.37% Verdad Advisers, LP 3Y 1.11% SUPERSTRING CAPITAL MANAGEMENT LP 0.97% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.82% Peapod Lane Capital LLC 0.61% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 0.48% Kynam Capital Management, LP 3Y 0.42% BRAIDWELL LP 3Y 0.35% DIADEMA PARTNERS LP 0.33%

FAQ About SPHERA FUNDS MANAGEMENT LTD. and CLYM

These are the practical questions this page is built to answer before you even open the full history table.

How long has SPHERA FUNDS MANAGEMENT LTD. reported owning CLYM?

SPHERA FUNDS MANAGEMENT LTD. reported CLYM across 8 quarterly 13F filings, from 2024 Q2 through 2026 Q1.

What was the largest reported CLYM position in SPHERA FUNDS MANAGEMENT LTD.'s portfolio?

The largest reported portfolio weight for CLYM was 0.72% in 2025 Q4.

What is the latest reported CLYM position on this page?

The most recent filing on this page is 2026 Q1, when SPHERA FUNDS MANAGEMENT LTD. reported 419,247 shares, equal to 0.46% of portfolio, with an estimated market value of $2.9M.

What does the chart on this CLYM ownership page compare?

The chart compares SPHERA FUNDS MANAGEMENT LTD.'s quarterly CLYM portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did SPHERA FUNDS MANAGEMENT LTD. time their CLYM position?

Based on 13F filing dates vs. subsequent CLYM price moves, SPHERA FUNDS MANAGEMENT LTD. correctly timed 3 out of 7 reported position changes (43%). The annualised alpha on CLYM relative to SPY over the holding period was +15.9%.

← Back to SPHERA FUNDS MANAGEMENT LTD. Holdings